Filing Details
- Accession Number:
- 0001181431-11-013837
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-03-01 12:56:01
- Reporting Period:
- 2011-02-25
- Filing Date:
- 2011-03-01
- Accepted Time:
- 2011-03-01 12:56:01
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 820096 | Perrigo Co | PRGO | Pharmaceutical Preparations (2834) | 382799573 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1321178 | Moshe Arkin | C/O Perrigo Company 515 Eastern Avenue Allegan MI 49010 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2011-02-25 | 24,970 | $75.28 | 6,240,128 | No | 4 | S | Indirect | By Nichsei Arkin Ltd. |
| Common Stock | Disposition | 2011-02-25 | 18,904 | $75.81 | 6,221,224 | No | 4 | S | Indirect | By Nichsei Arkin Ltd. |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Indirect | By Nichsei Arkin Ltd. |
| No | 4 | S | Indirect | By Nichsei Arkin Ltd. |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 1,130 | Direct |
Footnotes
- The price in column 4 is a weighted average. The prices actually received ranged from $74.71 to $75.71. For all transactions reported in this Form 4 utilizing a weighted average price, the reporting person undertakes to provide upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range.
- The price in column 4 is a weighted average. The prices actually received ranged from $75.72 to $75.93. For all transactions reported in this Form 4 utilizing a weighted average price, the reporting person undertakes to provide upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range.
Billionaire Hedge Funds
